Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M34.9Revenue $M6.2Net Margin (%)-181,144.1Z-Score-7.0
Enterprise Value $M-7.0EPS $0.2Operating Margin %-214,545.9F-Score4
P/E(ttm))0Cash Flow Per Share $-1.4Pre-tax Margin (%)-198,663.3Higher ROA y-yN
Price/Book4.310-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-12.6Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-52.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-214.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M57.9ROI % (ttm)-76.6Gross Margin Increase y-yY

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEZSJean-Marie Eveillard 2010-03-31 Sold Out $4.8 - $5.58
($4.98)
$ 0.53-89%Sold Out0
AEZSJean-Marie Eveillard 2009-12-31 Reduce$4.74 - $7.5
($6.12)
$ 0.53-91%Reduce -91.09%124,518
AEZSJean-Marie Eveillard 2009-09-30 Buy 0.02%$5.34 - $16.98
($9.72)
$ 0.53-94%New holding, 1397897 sh.1,397,897
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEZS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AEZS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about AEZS :

Quarterly/Annual Reports about AEZS:

    News about AEZS:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    comment on AEZS Oct 26 2011 
    Opportunistic Coat-tailing Jan 05 2010 

    More From Other Websites
    INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000... Nov 21 2014
    Nasdaq stocks posting largest volume increases Nov 21 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Aeterna... Nov 21 2014
    SHAREHOLDER ALERT: Class Action Lawsuit Against Aeterna Zentaris Inc. Filed By Glancy Binkow &... Nov 21 2014
    November 20, 2014 Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in... Nov 20 2014
    Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer Nov 20 2014
    Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer Nov 20 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Nov 18 2014
    Notice of Filing of Securities Fraud Class Action Against Aeterna Zentaris Inc. by Kantrowitz,... Nov 17 2014
    Notice of Filing of Securities Fraud Class Action against Aeterna Zentaris Inc. by Abraham, Fruchter... Nov 17 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aeterna... Nov 14 2014
    EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against Aeterna Zentaris, Inc.... Nov 11 2014
    INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000... Nov 11 2014
    INVESTOR ALERT: Investigation of Aeterna Zentaris, Inc. Announced by Glancy Binkow & Goldberg LLP Nov 10 2014
    SHAREHOLDER ALERT: Investigation on Behalf of Aeterna Zentaris, Inc. Investors Announced by Law... Nov 07 2014
    The Rosen Law Firm Announces Investigation of Securities Claims Against Aeterna Zentaris, Inc. Nov 06 2014
    Midday movers: Kate Spade, Apple, Hospira & more Nov 06 2014
    Aeterna Zentaris downgraded by H.C. Wainwright Nov 06 2014
    November 6, 2014 FDA Issues Complete Response Letter for Aeterna Zentaris’ MacrilenTM NDA in Adult... Nov 06 2014
    FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone... Nov 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK